ArticlePharmaceuticals (Basel, Switzerland)2026
Off-Label Ustekinumab and Vedolizumab in Pediatric Anti-TNFα Refractory IBD: Therapeutic Drug Monitoring Insights from a Case Series.
Stefania Cheli, Giulia Mosini, Vera Battini, Carla Carnovale, Sonia Radice, Marta Lebiu, Alessandro Cattoni, Giovanna Zuin, Emilio Clementi
Abstract readCase Reports
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Stefania CheliICPS, Pharmacovigilance & Clinical Research, Department of Biomedical and Clinical Sciences, University Hospital Luigi Sacco, ASST Fatebenefratelli Sacco, Università degli Studi di Milano, 20157 Milan, Italy.ORCID 0000-0002-2837-5248 Giulia MosiniICPS, Pharmacovigilance & Clinical Research, Department of Biomedical and Clinical Sciences, University Hospital Luigi Sacco, ASST Fatebenefratelli Sacco, Università degli Studi di Milano, 20157 Milan, Italy.
Vera BattiniICPS, Pharmacovigilance & Clinical Research, Department of Biomedical and Clinical Sciences, University Hospital Luigi Sacco, ASST Fatebenefratelli Sacco, Università degli Studi di Milano, 20157 Milan, Italy.ORCID 0000-0002-3513-9593 Carla CarnovaleICPS, Pharmacovigilance & Clinical Research, Department of Biomedical and Clinical Sciences, University Hospital Luigi Sacco, ASST Fatebenefratelli Sacco, Università degli Studi di Milano, 20157 Milan, Italy.
Sonia RadiceICPS, Pharmacovigilance & Clinical Research, Department of Biomedical and Clinical Sciences, University Hospital Luigi Sacco, ASST Fatebenefratelli Sacco, Università degli Studi di Milano, 20157 Milan, Italy.
Marta LebiuPediatric Department Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
Alessandro CattoniPediatric Department Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
Giovanna ZuinPediatric Department Fondazione IRCCS San Gerardo dei Tintori, 20900 Monza, Italy.
Emilio ClementiICPS, Pharmacovigilance & Clinical Research, Department of Biomedical and Clinical Sciences, University Hospital Luigi Sacco, ASST Fatebenefratelli Sacco, Università degli Studi di Milano, 20157 Milan, Italy.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
case seriespediatric inflammatory bowel diseasetherapeutic drug monitoringustekinumabvedolizumab
Identifiers
PMID41599751
PMCPMC12845042
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390